Design, synthesis, and LFA-1/ICAM-1 antagonist activity evaluation of Lifitegrast analogues
- 17 February 2022
- journal article
- research article
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 31 (4) , 555-579
Abstract
The interaction between Lymphocyte function-associated antigen 1 (LFA-1) and intercellular-adhesion molecule-1 (ICAM-1) plays important roles in the cell-mediated immune response and inflammation associated with dry eye disease. LFA-1/ICAM-1 antagonists can be used for the treatment of dry eye disease, such as Lifitegrast which has been approved by the FDA in 2016 as a new drug for the treatment of dry eye disease. In this study, we designed and synthesized some new structure compounds that are analogues to Lifitegrast, and their biological activities were evaluated by in vitro cell-based assay and also by in vivo mouse dry eye model. Our results demonstrated that one of these analogues of Lifitegrast (compound 1b) showed good LFA-1/ICAM-1 antagonist activity in in vitro assay; meanwhile, it also significantly reduced ocular surface epithelial cells damage, increased goblet cell density in dry eye mouse and highly improved the symptoms of dry eye mouse. Graphical abstractKeywords
Funding Information
- Technology Program of Liaoning (2019JH2/10300011)
This publication has 35 references indexed in Scilit:
- Rapid Discovery of Highly Potent and Selective Inhibitors of Histone Deacetylase 8 Using Click Chemistry to Generate Candidate LibrariesJournal of Medicinal Chemistry, 2012
- Discovery and Development of Potent LFA-1/ICAM-1 Antagonist SAR 1118 as an Ophthalmic Solution for Treating Dry EyeACS Medicinal Chemistry Letters, 2012
- Interferon-γ Exacerbates Dry Eye–Induced Apoptosis in Conjunctiva through Dual Apoptotic PathwaysInvestigative Ophthalmology & Visual Science, 2011
- The relationship between clinical signs and dry eye symptomsEye, 2011
- Discovery of tetrahydroisoquinoline (THIQ) derivatives as potent and orally bioavailable LFA-1/ICAM-1 antagonistsBioorganic & Medicinal Chemistry Letters, 2010
- Comparison of inhibitory activity of isomeric triazolopyridine derivatives towards adenosine receptor subtypes or do similar structures reveal similar bioactivities?Bioorganic & Medicinal Chemistry Letters, 2004
- ChemInform Abstract: Palladium-Catalyzed Cyanation of Hindered, Electron-Rich Aryl Triflates by Zinc Cyanide.ChemInform, 1998
- Structure−Activity Studies for a Novel Series ofN-(Arylethyl)-N-(1,2,3,4-tetrahydronaphthalen-1-ylmethyl)-N-methylamines Possessing Dual 5-HT Uptake Inhibiting and α2-Antagonistic ActivitiesJournal of Medicinal Chemistry, 1997
- ChemInform Abstract: Chemoselective Deprotection of Benzyl Esters, e.g. (I), in the Presence of Benzyl Ethers, Benzyloxymethyl Ethers, and N-Benzyl Groups by Catalytic Transfer Hydrogenation.ChemInform, 1992
- Synthesis of DL-[3-11C]phenylalanineThe International Journal of Applied Radiation and Isotopes, 1984